From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation

Published:2020-01 Issue: Volume:39 Page:100613
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Spadarella Gaia,Di Minno Alessandro,Donati Maria Benedetta,Mormile Mauro,Ventre Itala,Di Minno Giovanni

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference171 articles.

1. Discovery of anticoagulant drugs: a historical perspective;Gomez-Outes;Curr Drug Discov Technol,2012

2. The artificial kidney: a dialyser with a great area. 1944;Kolff;J Am Soc Nephrol,1997

3. Historical aspects of cardiopulmonary bypass: from antiquity to acceptance;Stammers;J Cardiothorac Vasc Anesth,1997

4. Heparin and thrombosis: a seventy year long story;Verstraete;Haemostasis.,1990

5. History of heparin;Barrowcliffe;Handb Exp Pharmacol,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanopore-regulated in situ polymerization for synthesis of homogeneous heparan sulfate with low dispersity;Carbohydrate Polymers;2024-10

2. Quality control, safety assessment and preparation approaches of low molecular weight heparin;Carbohydrate Polymers;2024-09

3. Fondaparinux sodium combined with conventional therapy improves subchorionic hematoma with protein S deficiency;Technology and Health Care;2024-07-30

4. A computationally guided study of a blood heat exchanger and the construction of an extracorporeal circulation system for selective brain cooling;Cell Reports Physical Science;2024-06

5. Scientific considerations in the regulatory approval of generic (or biosimilar) version of enoxaparin sodium – A lifesaving carbohydrate polymer;Regulatory Toxicology and Pharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3